ES2937965T3 - Microbiota fecal para el tratamiento de pacientes con trasplante de células madre hematopoyéticas - Google Patents
Microbiota fecal para el tratamiento de pacientes con trasplante de células madre hematopoyéticas Download PDFInfo
- Publication number
- ES2937965T3 ES2937965T3 ES18702952T ES18702952T ES2937965T3 ES 2937965 T3 ES2937965 T3 ES 2937965T3 ES 18702952 T ES18702952 T ES 18702952T ES 18702952 T ES18702952 T ES 18702952T ES 2937965 T3 ES2937965 T3 ES 2937965T3
- Authority
- ES
- Spain
- Prior art keywords
- fecal microbiota
- sample
- transplantation
- patient
- hsc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1750629A FR3062063B1 (fr) | 2017-01-26 | 2017-01-26 | Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques |
| PCT/EP2018/051941 WO2018138251A1 (fr) | 2017-01-26 | 2018-01-26 | Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2937965T3 true ES2937965T3 (es) | 2023-04-03 |
Family
ID=59325347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18702952T Active ES2937965T3 (es) | 2017-01-26 | 2018-01-26 | Microbiota fecal para el tratamiento de pacientes con trasplante de células madre hematopoyéticas |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20200188450A1 (enExample) |
| EP (1) | EP3573631B1 (enExample) |
| JP (1) | JP7527109B2 (enExample) |
| KR (1) | KR102517287B1 (enExample) |
| CN (1) | CN110520141A (enExample) |
| AU (1) | AU2018212530B2 (enExample) |
| CA (1) | CA3051807C (enExample) |
| DK (1) | DK3573631T3 (enExample) |
| ES (1) | ES2937965T3 (enExample) |
| FI (1) | FI3573631T3 (enExample) |
| FR (1) | FR3062063B1 (enExample) |
| HR (1) | HRP20230122T1 (enExample) |
| HU (1) | HUE061155T2 (enExample) |
| IL (1) | IL268237B (enExample) |
| LT (1) | LT3573631T (enExample) |
| PL (1) | PL3573631T3 (enExample) |
| PT (1) | PT3573631T (enExample) |
| RS (1) | RS63978B1 (enExample) |
| SI (1) | SI3573631T1 (enExample) |
| WO (1) | WO2018138251A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200038506A (ko) * | 2017-08-07 | 2020-04-13 | 핀치 테라퓨틱스, 인코포레이티드 | 건강한 장 장벽을 유지 및 회복시키기 위한 조성물 및 방법 |
| US20220023419A1 (en) * | 2018-11-28 | 2022-01-27 | The Council Of The Queensland Institute Of Medical Research | Inhibiting inflammation |
| CN112375705A (zh) * | 2020-11-12 | 2021-02-19 | 安徽燕婉健康科技有限公司 | 一种替代天然菌群的肠壁移植优势菌的制备方法及其应用 |
| EP4386090A1 (en) * | 2022-12-12 | 2024-06-19 | Assistance Publique - Hôpitaux De Paris | Method for determining and improving the potential efficacy of anticancer treatment |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2649719B1 (fr) * | 1989-07-17 | 1993-08-27 | Cerbio Sa | Procede de protection et de conservation de micro-organismes notamment de bacteries |
| BR112013022927A2 (pt) * | 2011-03-09 | 2016-12-06 | Univ Minnesota | composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição |
| CN104918624A (zh) * | 2012-11-26 | 2015-09-16 | 托马斯·朱利叶斯·波洛迪 | 恢复排泄物微生物群的组合物及其制造和使用方法 |
| WO2016057671A1 (en) * | 2014-10-07 | 2016-04-14 | University Of Virginia Patent Foundation | Compositions and methods for preventing and treating infection |
| ES3010296T3 (en) * | 2014-11-25 | 2025-04-02 | Memorial Sloan Kettering Cancer Center | Intestinal microbiota and gvhd |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| FR3035328B1 (fr) * | 2015-04-24 | 2019-08-23 | Maat Pharma | Procede de preparation d'un echantillon de microbiote fecal |
| US20180185421A1 (en) * | 2016-08-29 | 2018-07-05 | Tokyo Metropolitan Government | Composition comprising fecal microbiota |
-
2017
- 2017-01-26 FR FR1750629A patent/FR3062063B1/fr not_active Expired - Fee Related
-
2018
- 2018-01-26 IL IL268237A patent/IL268237B/en unknown
- 2018-01-26 DK DK18702952.5T patent/DK3573631T3/da active
- 2018-01-26 PL PL18702952.5T patent/PL3573631T3/pl unknown
- 2018-01-26 AU AU2018212530A patent/AU2018212530B2/en active Active
- 2018-01-26 HU HUE18702952A patent/HUE061155T2/hu unknown
- 2018-01-26 SI SI201830842T patent/SI3573631T1/sl unknown
- 2018-01-26 CA CA3051807A patent/CA3051807C/fr active Active
- 2018-01-26 JP JP2019540408A patent/JP7527109B2/ja active Active
- 2018-01-26 FI FIEP18702952.5T patent/FI3573631T3/fi active
- 2018-01-26 EP EP18702952.5A patent/EP3573631B1/fr active Active
- 2018-01-26 LT LTEPPCT/EP2018/051941T patent/LT3573631T/lt unknown
- 2018-01-26 PT PT187029525T patent/PT3573631T/pt unknown
- 2018-01-26 WO PCT/EP2018/051941 patent/WO2018138251A1/fr not_active Ceased
- 2018-01-26 RS RS20230101A patent/RS63978B1/sr unknown
- 2018-01-26 HR HRP20230122TT patent/HRP20230122T1/hr unknown
- 2018-01-26 ES ES18702952T patent/ES2937965T3/es active Active
- 2018-01-26 CN CN201880008477.0A patent/CN110520141A/zh active Pending
- 2018-01-26 US US16/480,863 patent/US20200188450A1/en not_active Abandoned
- 2018-01-26 KR KR1020197024970A patent/KR102517287B1/ko active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR102517287B1 (ko) | 2023-03-31 |
| PL3573631T3 (pl) | 2023-05-02 |
| RS63978B1 (sr) | 2023-03-31 |
| IL268237A (en) | 2019-09-26 |
| AU2018212530A1 (en) | 2019-09-05 |
| EP3573631A1 (fr) | 2019-12-04 |
| SI3573631T1 (sl) | 2023-09-29 |
| US20200188450A1 (en) | 2020-06-18 |
| AU2018212530B2 (en) | 2022-06-23 |
| CN110520141A (zh) | 2019-11-29 |
| PT3573631T (pt) | 2023-01-24 |
| FR3062063B1 (fr) | 2019-04-19 |
| CA3051807A1 (fr) | 2018-08-02 |
| FI3573631T3 (fi) | 2023-03-02 |
| JP7527109B2 (ja) | 2024-08-02 |
| KR20190130563A (ko) | 2019-11-22 |
| FR3062063A1 (fr) | 2018-07-27 |
| HUE061155T2 (hu) | 2023-05-28 |
| JP2020506183A (ja) | 2020-02-27 |
| WO2018138251A1 (fr) | 2018-08-02 |
| HRP20230122T1 (hr) | 2023-03-31 |
| CA3051807C (fr) | 2023-07-11 |
| IL268237B (en) | 2022-07-01 |
| EP3573631B1 (fr) | 2022-11-16 |
| LT3573631T (lt) | 2023-03-10 |
| DK3573631T3 (da) | 2023-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107530280B (zh) | 粪便微生物群样品的制备方法 | |
| EP3823650B1 (en) | Fecal microbiota composition, for use in reducing treatment-induced inflammation | |
| AU2018212530B2 (en) | Fecal microbiota for treating patients undergoing a hematopoietic stem cell transplant | |
| CN108430481A (zh) | 冻干粪便微生物群样品的方法 | |
| AU2019229721A1 (en) | Stool collection method and sample preparation method for transplanting fecal microbiota | |
| US20200038459A1 (en) | Composition comprising fecal microbiota | |
| ES2982241T3 (es) | Células T reguladoras derivadas de tejido tímico y uso de dichas células como inmunoterapia celular en trastornos del sistema inmunitario | |
| STOCKSCHLA¨ DER et al. | Long‐term follow‐up of leukaemia patients after related cryopreserved allogeneic bone marrow transplantation | |
| CN114164112A (zh) | 一种微生物保护组合物及其制备方法和应用 | |
| RU2612090C1 (ru) | Способ лечения местнораспространённого нерезектабельного рака пищевода | |
| Parikh et al. | Reduced-intensity conditioning (RIC) in children with nonmalignant disorders (NMD) undergoing unrelated donor umbilical cord blood transplantation (UCBT) | |
| Kennedy-Nasser et al. | 223: Alternative Donor Hematopoietic Stem Cell Transplantation for Pediatric Patients with Acute Lymphoblastic Leukemia Using Campath in a Myeloablative Conditioning Regimen | |
| Schneiderman et al. | 222: Donor Chimerism Kinetics in Pediatric Patients Undergoing Reduced Intensity Conditioning (RIC) with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) | |
| Sung et al. | Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center | |
| Alvaro et al. | Leak Treatment in Pancreas Transplant: 753 | |
| Storb | Treatment of Acute Leukemia in Remission by Bone Marrow Transplantation | |
| Wingard | Past, Present, Future | |
| Kido et al. | Allogeneic and autologous stem cell transplantation in advanced small round cell sarcomas | |
| Ghavamzadeh et al. | Gastrointestinal Bleeding, the First Presentation of Acute GVHD in Two Patients with Thalassemia after BMT | |
| Grochowiecki et al. | The Timing and a Cause of the Graft Pancreatectomy Has an Impact on the Simultaneous Pancreas and Kidney Recipient Survival: 449 | |
| Kebriaei et al. | Inferior Outcome With Addition Of Rituximab For Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Acute Lymphoblastic Leukemia (ALL) | |
| Parikh et al. | Outcomes of Unrelated Umbilical Cord Blood Transplantation In Pediatric Patients With Primary and Secondary Myelodysplastic Syndromes | |
| Warnecke et al. | PROLONGED TRANSPLANT SURVIVAL AFTER DONOR MACROPHAGE TRANSFUSION IN PORCINE PULMONARY TRANSPLANTATION: 2229 | |
| Mazumder et al. | Salvage and Hematopoietic Recovery With Bortezomib and Melphalan In Cytopenic Recurrent and Refractory Multiple Myeloma |